Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

ARMISTICE CAPITAL, LLC

2. Date of Event Requiring Statement (Month/Day/Year)
04/13/2018

3. Issuer Name and Ticker or Trading Symbol
EYEGATE PHARMACEUTICALS INC [EYEG]

(Last)

(First)

(Middle)

510 MADISON AVENUE, 22ND FLOOR

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

NEW YORK, NY 10022

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 par value	3,232,530	D ⁽¹⁾
Common Stock, $0.01 par value	3,232,530	I	See Footnote ⁽²⁾
Common Stock, $0.01 par value	3,232,530	I	See Footnote ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrants	06/14/2017⁽³⁾	06/14/2022	Common Stock	2,000,000	$ 1.5	D ⁽¹⁾
Warrants	06/14/2017⁽³⁾	06/14/2022	Common Stock	2,000,000	$ 1.5	I	See Footnote ⁽²⁾
Warrants	06/14/2017⁽³⁾	06/14/2022	Common Stock	2,000,000	$ 1.5	I	See Footnote ⁽²⁾
Warrants	04/17/2018⁽³⁾	04/17/2023	Common Stock	15,937,500	$ 0.32	D ⁽¹⁾
Warrants	04/17/2018⁽⁴⁾	04/17/2023	Common Stock	15,937,500	$ 0.32	I	See Footnote ⁽²⁾
Warrants	04/17/2018⁽⁴⁾	04/17/2023	Common Stock	15,937,500	$ 0.32	I	See Footnote ⁽²⁾
Series C Convertible Preferred Stock	04/17/2018⁽⁵⁾	⁽⁵⁾	Common Stock	12,787,500	$ 0.32	D ⁽¹⁾
Series C Convertible Preferred Stock	04/17/2018⁽⁵⁾	⁽⁵⁾	Common Stock	12,787,500	$ 0.32	I	See Footnote ⁽²⁾
Series C Convertible Preferred Stock	04/17/2018⁽⁵⁾	⁽⁵⁾	Common Stock	12,787,500	$ 0.32	I	See Footnote ⁽²⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 22ND FLOOR NEW YORK, NY 10022		X
Armistice Capital Master Fund Ltd. 510 MADISON AVENUE, 22ND FLOOR NEW YORK, NY 10022		X
Boyd Steven 510 MADISON AVENUE, 22ND FLOOR NEW YORK, NY 10022		X

Signatures

Armistice Capital, LLC, By: /s/ Steven Boyd, Managing Member		04/17/2018
^**Signature of Reporting Person		Date
Armistice Capital Master Fund, Ltd., By:/s/ Steven Boyd, Director		04/17/2018
^**Signature of Reporting Person		Date
/s/ Steven Boyd		04/17/2018
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reported securities are directly owned by Armistice Capital Master Fund, Ltd.
(2)	The reported securities are directly owned by Armistice Capital Master Fund, Ltd., a Cayman Islands corporation, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund, Ltd. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital, LLC and Director of Armistice Capital Master Fund, Ltd.
(3)	These warrants are currently excercisable, subject to a blocker provision that prevents Armistice Capital Master Fund, Ltd.from exercising the warrants if it would be more than a 4.99% beneficial owner of the Common Shares following such exercise.
(4)	These warrants are currently excercisable, subject to a blocker provision that prevents Armistice Capital Master Fund, Ltd.from exercising the warrants if it would be more than a 9.99% beneficial owner of the Common Shares following such exercise.
(5)	The Series C Convertible Preferred Stock has no expiration date and is convertible at any time at the option of Armistice Capital Master Fund, Ltd., subject to a blocker provision that prevents Armistice Capital Master Fund, Ltd.from converting the Series C Convertible Preferred Stock into Common Shares if it would be more than a 4.99% beneficial owner of the Common Shares following such conversion.
Remarks: Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.